Verastem Non Current Liabilities Total from 2010 to 2025
| VSTM Stock | USD 5.10 0.06 1.16% |
Non Current Liabilities Total | First Reported 2011-09-30 | Previous Quarter 99.5 M | Current Value 128.5 M | Quarterly Volatility 40.8 M |
Check Verastem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Verastem's main balance sheet or income statement drivers, such as Other Operating Expenses of 78.5 M, Research Development of 41.3 M or Total Operating Expenses of 75.8 M, as well as many indicators such as Price To Sales Ratio of 32.08, Dividend Yield of 0.0 or Days Sales Outstanding of 7.98. Verastem financial statements analysis is a perfect complement when working with Verastem Valuation or Volatility modules.
Verastem | Non Current Liabilities Total | Build AI portfolio with Verastem Stock |
Latest Verastem's Non Current Liabilities Total Growth Pattern
Below is the plot of the Non Current Liabilities Total of Verastem over the last few years. It is Verastem's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Verastem's overall financial position and show how it may be relating to other accounts over time.
| Non Current Liabilities Total | 10 Years Trend |
|
Non Current Liabilities Total |
| Timeline |
Verastem Non Current Liabilities Total Regression Statistics
| Arithmetic Mean | 42,312,119 | |
| Geometric Mean | 7,190,039 | |
| Coefficient Of Variation | 105.80 | |
| Mean Deviation | 39,208,134 | |
| Median | 25,996,000 | |
| Standard Deviation | 44,767,530 | |
| Sample Variance | 2004.1T | |
| Range | 115.8M | |
| R-Value | 0.35 | |
| Mean Square Error | 1891.5T | |
| R-Squared | 0.12 | |
| Significance | 0.19 | |
| Slope | 3,245,192 | |
| Total Sum of Squares | 30062T |
Verastem Non Current Liabilities Total History
About Verastem Financial Statements
Verastem investors utilize fundamental indicators, such as Non Current Liabilities Total, to predict how Verastem Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Non Current Liabilities Total | 99.5 M | 104.4 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Verastem Correlation against competitors. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.36) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.